Merit Medical Systems Inc (MMSI)
77.03
+0.40
(+0.52%)
USD |
NASDAQ |
May 02, 16:00
77.00
-0.03
(-0.04%)
Pre-Market: 20:00
Merit Medical Systems Enterprise Value: 4.694B for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 4.694B |
| May 01, 2024 | 4.671B |
| April 30, 2024 | 4.524B |
| April 29, 2024 | 4.581B |
| April 26, 2024 | 4.505B |
| April 25, 2024 | 4.482B |
| April 24, 2024 | 4.520B |
| April 23, 2024 | 4.528B |
| April 22, 2024 | 4.474B |
| April 19, 2024 | 4.403B |
| April 18, 2024 | 4.343B |
| April 17, 2024 | 4.373B |
| April 16, 2024 | 4.445B |
| April 15, 2024 | 4.399B |
| April 12, 2024 | 4.438B |
| April 11, 2024 | 4.493B |
| April 10, 2024 | 4.399B |
| April 09, 2024 | 4.431B |
| April 08, 2024 | 4.464B |
| April 05, 2024 | 4.422B |
| April 04, 2024 | 4.398B |
| April 03, 2024 | 4.451B |
| April 02, 2024 | 4.418B |
| April 01, 2024 | 4.583B |
| March 31, 2024 | 4.619B |
| Date | Value |
|---|---|
| March 28, 2024 | 4.634B |
| March 27, 2024 | 4.618B |
| March 26, 2024 | 4.469B |
| March 25, 2024 | 4.462B |
| March 22, 2024 | 4.435B |
| March 21, 2024 | 4.479B |
| March 20, 2024 | 4.468B |
| March 19, 2024 | 4.480B |
| March 18, 2024 | 4.428B |
| March 15, 2024 | 4.399B |
| March 14, 2024 | 4.403B |
| March 13, 2024 | 4.465B |
| March 12, 2024 | 4.518B |
| March 11, 2024 | 4.558B |
| March 08, 2024 | 4.592B |
| March 07, 2024 | 4.602B |
| March 06, 2024 | 4.572B |
| March 05, 2024 | 4.587B |
| March 04, 2024 | 4.668B |
| March 01, 2024 | 4.654B |
| February 29, 2024 | 4.650B |
| February 28, 2024 | 4.878B |
| February 27, 2024 | 4.898B |
| February 26, 2024 | 4.858B |
| February 23, 2024 | 4.854B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.543B
Minimum
Oct 31 2019
5.150B
Maximum
Jul 14 2023
3.583B
Average
3.647B
Median
Enterprise Value Benchmarks
| Becton Dickinson & Co | 84.37B |
| Integer Holdings Corp | 4.781B |
| Abbott Laboratories | 191.41B |
| Insulet Corp | 12.84B |
| West Pharmaceutical Services Inc | 26.44B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 28.24M |
| Revenue (Quarterly) | 323.51M |
| Total Expenses (Quarterly) | 287.70M |
| EPS Diluted (Quarterly) | 0.48 |
| Gross Profit Margin (Quarterly) | 46.90% |
| Profit Margin (Quarterly) | 8.73% |
| Earnings Yield | 2.27% |
| Operating Earnings Yield | 2.99% |
| Normalized Earnings Yield | 2.296 |